Genzyme Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genzyme Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3407
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosis I, multiple sclerosis, Gaucher disease type 1, long-term enzyme replacement therapy, acute lymphoblastic leukemia, atopic dermatitis, management of uric acid levels, fabry disease, rheumatoid arthritis, Pompe disease, non-Hodgkin’s lymphoma, multiple myleoma, gastric adenocarcinoma and squamous cell carcinoma, and kidney transplant acute rejection. The company has several more products in various stages of development. It operates a research and development lab and manufacturing plants in the US, Belgium and Ireland. The company has presence across the world. Genzyme is headquartered in Massachusetts, the US.

Genzyme Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genzyme Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Genzyme Corp, Medical Devices Deals, 2012 to YTD 2018 10
Genzyme Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Genzyme Corp, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Genzyme Acquires Caprelsa from AstraZeneca 13
Genzyme Completes Acquisition Of Leukine Manufacturing Facility From Bayer HealthCare For US$98.5 Million 14
Venture Financing 15
Edimer Pharma Raises US$18 Million In Series B Financing 15
Ultragenyx Pharma Raises US$75 Million In Series B Financing 17
Partnerships 19
Alnylam Pharma Enters into Agreement with Sanofi Genzyme 19
Sanofi Genzyme Enters into Research Agreement with Johns Hopkins School of Medicine 20
Recursion Pharma Enters into Research Agreement with Genzyme 21
Ablynx Enters into Research Agreement with Genzyme 22
Voyager Therapeutics Enters into Development Agreement with Genzyme 23
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 24
Charcot-Marie-Tooth Association Enters into Agreement with Genzyme to Discover Therapies for CMT1A 25
Genzyme Enters Into Research Agreement With Cleveland Clinic 26
Alnylam Pharma And Genzyme Enter Into Agreement For RNAi Therapeutics As Genetic Medicines 27
Alnylam Pharma And Genzyme Expands Co-Development Agreement For RNAi Therapeutics 29
Merger 30
Sanofi Japan and Genzyme Japan Merge 30
Licensing Agreements 31
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 31
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 32
Equity Offering 33
Alnylam Pharma Raises USD70.7 Million in Private Placement of Shares 33
KaloBios Pharma Completes IPO For US$70 Million 34
Asset Transactions 36
Admedus Acquires Manufacturing Facility From Genzyme Australasia 36
Genzyme Corp – Key Competitors 37
Genzyme Corp – Key Employees 38
Genzyme Corp – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Joint Venture 41
Recent Developments 42
Clinical Trials 42
Apr 11, 2017: Sanofi Genzyme to present data on GLD52 (GZ402668) at AAN 42
Feb 14, 2017: Sanofi Initiates Phase 2 Clinical Trial to Evaluate Therapy for Genetic Form of Parkinson’s Disease 43
Other Significant Developments 44
Mar 22, 2017: Sanofi Genzyme Extends Its Multiple Myeloma Journey Partners Program To Cities Nationwide To Help Improve Patient Outcomes Through Peer-to-Peer Education 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Genzyme Corp, Pharmaceuticals & Healthcare, Key Facts 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genzyme Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genzyme Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Genzyme Corp, Medical Devices Deals, 2012 to YTD 2018 10
Genzyme Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Genzyme Acquires Caprelsa from AstraZeneca 13
Genzyme Completes Acquisition Of Leukine Manufacturing Facility From Bayer HealthCare For US$98.5 Million 14
Edimer Pharma Raises US$18 Million In Series B Financing 15
Ultragenyx Pharma Raises US$75 Million In Series B Financing 17
Alnylam Pharma Enters into Agreement with Sanofi Genzyme 19
Sanofi Genzyme Enters into Research Agreement with Johns Hopkins School of Medicine 20
Recursion Pharma Enters into Research Agreement with Genzyme 21
Ablynx Enters into Research Agreement with Genzyme 22
Voyager Therapeutics Enters into Development Agreement with Genzyme 23
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 24
Charcot-Marie-Tooth Association Enters into Agreement with Genzyme to Discover Therapies for CMT1A 25
Genzyme Enters Into Research Agreement With Cleveland Clinic 26
Alnylam Pharma And Genzyme Enter Into Agreement For RNAi Therapeutics As Genetic Medicines 27
Alnylam Pharma And Genzyme Expands Co-Development Agreement For RNAi Therapeutics 29
Sanofi Japan and Genzyme Japan Merge 30
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 31
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 32
Alnylam Pharma Raises USD70.7 Million in Private Placement of Shares 33
KaloBios Pharma Completes IPO For US$70 Million 34
Admedus Acquires Manufacturing Facility From Genzyme Australasia 36
Genzyme Corp, Key Competitors 37
Genzyme Corp, Key Employees 38
Genzyme Corp, Other Locations 39
Genzyme Corp, Subsidiaries 39
Genzyme Corp, Joint Venture 41

List of Figures
Genzyme Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genzyme Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Genzyme Corp, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Genzyme Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GlobalData plc (PRO):企業の財務・戦略的SWOT分析
    Summary GlobalData Plc (GD), formerly Progressive Digital Media Group Plc, is a provider of data insights, analytics and information services. The company’s solutions encompass market and competitive analysis, strategic planning, mergers and acquisitions, financial decisions, legal and accounting, m …
  • RuralMetro Corp:企業の戦略的SWOT分析
    RuralMetro Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Silex Systems Ltd (SLX):企業の財務・戦略的SWOT分析
    Summary Silex Systems Ltd (Silex) is a research and development company that offers technology solutions. The company develops, and commercializes technologies in solar energy, nuclear energy, and advanced materials and instrumentation. It develops utility-scale concentrating photovoltaic technology …
  • Canada Bread Company, Limited:企業の戦略・SWOT・財務情報
    Canada Bread Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Canada Bread Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Vital Therapies Inc (VTL)-製薬・医療分野:企業M&A・提携分析
    Summary Vital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute l …
  • Beverages & More Inc:企業の戦略的SWOT分析
    Beverages & More Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • BPL Global LLC:企業の戦略的SWOT分析
    BPL Global LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Global Imaging Systems, Inc.:企業のM&A・事業提携・投資動向
    Global Imaging Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Global Imaging Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Armanino Foods of Distinction Inc.:企業の戦略・SWOT・財務情報
    Armanino Foods of Distinction Inc. - Strategy, SWOT and Corporate Finance Report Summary Armanino Foods of Distinction Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Sanmina Corporation (SANM):企業の財務・戦略的SWOT分析
    Sanmina Corporation (SANM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Petroleum Company of Trinidad and Tobago Ltd:企業の戦略的SWOT分析
    Petroleum Company of Trinidad and Tobago Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Berg LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Berg LLC (Berg) is a biopharmaceutical company that focus on therapeutic discovery using AI-based Interrogative biology platform. The company’s proprietary platform Interrogative Biology, combines patient biology and artificial intelligence-based analytics to understand predictive patterns o …
  • Sagent Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sagent Pharmaceuticals Inc (Sagent), formerly Sagent Holding Co, a subsidiary of Nichi-Iko Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and manufactures injectable products. The company offers products such as amikacin sulfate injection, USP, ampicillin and sulbactam f …
  • Biotronik SE & Co KG:企業の戦略的SWOT分析
    Biotronik SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • SpectraScience Inc (SCIE):企業の製品パイプライン分析2018
    Summary SpectraScience Inc (SpectraScience) is a medical device company, which undertakes the design, development, manufacture and marketing of light-based technology products. The company offers its proprietary WavSTAT Optical Biopsy System to diagnose tissue health optically by using light. This s …
  • AFC Energy plc (AFC):企業の財務・戦略的SWOT分析
    Summary AFC Energy Plc (AFC Energy) is a developer of alkaline fuel cells. The company's projects include Power-Up and Alkammonia. Its power generation technology is used in the industrial markets and produces heat, water, and electricity. AFC Energy provides its electricity for industrial applicati …
  • Campine NV (CAMB):企業の財務・戦略的SWOT分析
    Campine NV (CAMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Suburban Propane Partners, L.P.:企業の戦略・SWOT・財務情報
    Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • SBM Offshore NV (SBMO):石油・ガス:M&Aディール及び事業提携情報
    Summary SBM Offshore NV (SBM Offshore) is a floating production solutions provider for offshore oil and gas industry. The company designs supplies, installs and operates Floating Production, Storage and Offloading (FPSO) vessels. The company leases its FPSO vessels to its clients. It also undertakes …
  • CompuGroup Medical Deutschland AG (COP):医療機器:M&Aディール及び事業提携情報
    Summary CompuGroup Medical Deutschland AG (CGM) is a provider of medical software products and healthcare services. The company provides products such as communication solutions, software assisted medicine, dentist information systems, ambulatory information systems, drug safety and patient marketin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆